| Literature DB >> 27452772 |
Michael M Engelgau1, Emmanuel Peprah2, Uchechukwu K A Sampson2, Helena Mishoe2, Ivor J Benjamin3, Pamela S Douglas4, Judith S Hochman5, Paul M Ridker6, Neal Brandes7, William Checkley8, Sameh El-Saharty9, Majid Ezzati10, Anselm Hennis11, Lixin Jiang12, Harlan M Krumholz13, Gabrielle Lamourelle14, Julie Makani15, K M Venkat Narayan16, Kwaku Ohene-Frempong17, Sharon E Straus18, David Stuckler19, David A Chambers20, Deshirée Belis2, Glen C Bennett2, Josephine E Boyington21, Tony L Creazzo22, Janet M de Jesus2, Chitra Krishnamurti2, Mia R Lowden23, Antonello Punturieri24, Susan T Shero2, Neal S Young25, Shimian Zou26, George A Mensah2.
Abstract
Almost three-quarters (74%) of all the noncommunicable disease burden is found within low- and middle-income countries. In September 2014, the National Heart, Lung, and Blood Institute held a Global Health Think Tank meeting to obtain expert advice and recommendations for addressing compelling scientific questions for late stage (T4) research-research that studies implementation strategies for proven effective interventions-to inform and guide the National Heart, Lung, and Blood Institute's global health research and training efforts. Major themes emerged in two broad categories: 1) developing research capacity; and 2) efficiently defining compelling scientific questions within the local context. Compelling scientific questions included how to deliver inexpensive, scalable, and sustainable interventions using alternative health delivery models that leverage existing human capital, technologies and therapeutics, and entrepreneurial strategies. These broad themes provide perspectives that inform an overarching strategy needed to reduce the heart, lung, blood, and sleep disorders disease burden and global health disparities. Published by Elsevier B.V.Entities:
Mesh：
Year: 2016 PMID： 27452772 DOI： 10.1016/j.gheart.2016.03.640
Source DB: PubMed Journal: Glob Heart ISSN： 2211-8160